4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years ...
Finanznachrichten

4D Molecular Therapeutics, Inc.: 4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global ...

Canva’s AI design brain explained: How it works, secret tips for beginners

When Canva first appeared in 2013, it promised to make design accessible to everyone, no Photoshop skills required. Over a ...
MarTech on MSN

How small companies can win with account-based marketing

ABM isn’t just for enterprises. Smaller companies can now use AI, automation and focused targeting to drive efficiency, close ...